Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Enhanced antimalarial activity by a novel artemether-lumefantrine lipid emulsion for parenteral administration.

Ma Y, Lu T, Zhao W, Wang Y, Chen T, Mei Q, Chen T.

Antimicrob Agents Chemother. 2014 Oct;58(10):5658-65. doi: 10.1128/AAC.01428-13.

2.

Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.

Parashar D, Aditya NP, Murthy RS.

Drug Deliv. 2016;23(1):123-9. doi: 10.3109/10717544.2014.905883.

PMID:
24786480
3.

Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model.

Patil S, Suryavanshi S, Pathak S, Sharma S, Patravale V.

Int J Pharm. 2013 Oct 15;455(1-2):229-34. doi: 10.1016/j.ijpharm.2013.07.033.

PMID:
23886650
4.

The effect of lopinavir/ritonavir on the antimalarial activity of artemether or artemether/lumefantrine in a mouse model of Plasmodium berghei.

Abiodun OO, Akinbo J, Ojurongbe O.

J Chemother. 2015 Feb;27(1):25-8. doi: 10.1179/1973947813Y.0000000158.

PMID:
24621166
5.

Artemether-lumefantrine for uncomplicated malaria: a systematic review.

Omari AA, Gamble C, Garner P.

Trop Med Int Health. 2004 Feb;9(2):192-9. Review.

PMID:
15040555
6.

Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda.

Checchi F, Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor WR, Guthmann JP.

Malar J. 2006 Jul 19;5:59.

7.

Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.

Lefèvre G, Carpenter P, Souppart C, Schmidli H, McClean M, Stypinski D.

Br J Clin Pharmacol. 2002 Nov;54(5):485-92.

8.

A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.

Lefèvre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R.

Am J Trop Med Hyg. 2001 May-Jun;64(5-6):247-56.

9.

Artesunate + amodiaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in the Colombian Pacific region: a noninferiority trial.

De la Hoz Restrepo F, Porras Ramírez A, Rico Mendoza A, Córdoba F, Rojas DP.

Rev Soc Bras Med Trop. 2012 Dec;45(6):732-8.

10.

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.

White NJ, van Vugt M, Ezzet F.

Clin Pharmacokinet. 1999 Aug;37(2):105-25. Review.

PMID:
10496300
11.

Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.

Vaughan-Williams CH, Raman J, Raswiswi E, Immelman E, Reichel H, Gate K, Knight S.

Malar J. 2012 Dec 28;11:434. doi: 10.1186/1475-2875-11-434.

12.

Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study.

Lefèvre G, Bhad P, Jain JP, Kalluri S, Cheng Y, Dave H, Stein DS.

Malar J. 2013 Sep 8;12:312. doi: 10.1186/1475-2875-12-312.

13.

Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.

Pareek A, Chandurkar N, Srivastav V, Lakhani J, Karmakar PS, Basu S, Ray A, Pednekar S, Gupta PB, Suthar N, Lakhani S.

Trop Med Int Health. 2013 May;18(5):578-87. doi: 10.1111/tmi.12088.

14.

Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.

[No authors listed]

Prescrire Int. 2008 Apr;17(94):54-6.

PMID:
18516806
15.

Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.

Isacchi B, Bergonzi MC, Grazioso M, Righeschi C, Pietretti A, Severini C, Bilia AR.

Eur J Pharm Biopharm. 2012 Apr;80(3):528-34. doi: 10.1016/j.ejpb.2011.11.015.

PMID:
22142592
16.

A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.

Sagara I, Diallo A, Kone M, Coulibaly M, Diawara SI, Guindo O, Maiga H, Niambele MB, Sissoko M, Dicko A, Djimde A, Doumbo OK.

Am J Trop Med Hyg. 2008 Nov;79(5):655-61.

17.

Changes in antioxidant status and biochemical indices after acute administration of artemether, artemether-lumefantrine and halofantrine in rats.

Adaramoye OA, Osaimoje DO, Akinsanya AM, Nneji CM, Fafunso MA, Ademowo OG.

Basic Clin Pharmacol Toxicol. 2008 Apr;102(4):412-8. doi: 10.1111/j.1742-7843.2008.00211.x.

18.
19.

Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.

Omari AA, Gamble C, Garner P.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005564. Review.

PMID:
16235412
20.

Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005-2009.

Dorkenoo MA, Barrette A, Agbo YM, Bogreau H, Kutoati S, Sodahlon YK, Morgah K.

Malar J. 2012 Oct 8;11:338. doi: 10.1186/1475-2875-11-338.

Items per page

Supplemental Content

Support Center